首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans.
【2h】

Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans.

机译:在严重的联合免疫缺陷小鼠中植入有限的B细胞库这些小鼠植入了来自免疫缺陷或正常人的外周血单核细胞。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The ability to engraft human PBMC or fetal tissue immune cells in the severe combined immunodeficient (SCID) mouse has created a need for characterization of these systems and their application to disease models. We demonstrate that SCID mice reconstituted with PBMC support the growth and differentiation of a restricted set of B cells. Human IgG levels of 1-2 mg/ml (10-20% of normal human serum levels) were routinely achieved in spite of a serum half life of only 12 d. Ig levels peaked around 50 d and Ig production was maintained for greater than 100 d. The Ig was greater than 85% IgG though some IgM, IgA, IgD, and even IgE could be detected. However, the human IgG produced in hu-PBL-SCID mice was pauci-clonal when analyzed by isoelectric focusing and by kappa/lambda light chain usage. Using a new polymerase chain reaction based analysis capable of monitoring individual VH family utilization, we found that the engrafted B cells showed skewed and restricted human VH subfamily utilization. These parameters were markedly variable among hu-PBL-SCID mice reconstituted from the same donor cell population at both early (21-50 d) and late stages (greater than 100 d). Hu-PBL/CVI-SCID mice constructed with cells from patients with common variable immunodeficiency with an in vitro block in terminal B cell differentiation produced human Ig responses that were quantitatively the same as those produced by hu-PBL-SCID mice from normal donors. The hu-PBL-SCID system using PBMC appears to lead to growth and Ig production by a small number of B cells and results in a restricted B cell repertoire.
机译:将人PBMC或胎儿组织免疫细胞移植到严重的联合免疫缺陷(SCID)小鼠中的能力引起了对这些系统的表征及其在疾病模型中的应用的需求。我们证明用PBMC重组的SCID小鼠支持B细胞受限集的生长和分化。尽管血清半衰期仅为12 d,仍可常规达到1-2 mg / ml的人IgG水平(正常人血清水平的10-20%)。 Ig水平在50 d左右达到峰值,并且Ig产生维持超过100 d。尽管可以检测到一些IgM,IgA,IgD甚至IgE,但Ig仍大于85%IgG。然而,当通过等电聚焦和κ/λ轻链使用分析时,在hu-PBL-SCID小鼠中产生的人IgG是稀疏克隆的。使用新的基于聚合酶链反应的分析能够监测各个VH家族的利用,我们发现移植的B细胞显示出偏斜和受限的人类VH亚家族利用。这些参数在早期(21-50 d)和晚期(大于100 d)从相同供体细胞群体重构的hu-PBL-SCID小鼠中明显不同。使用来自具有共同可变免疫缺陷患者的细胞构建的Hu-PBL / CVI-SCID小鼠,其体外B细胞分化受到体外阻滞,产生的人Ig应答与来自正常供体的hu-PBL-SCID小鼠产生的Ig应答在数量上相同。使用PBMC的hu-PBL-SCID系统似乎会导致少量B细胞的生长和Ig产生,并导致有限的B细胞库。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号